Cold Plasma-Activated Water Shows Anti-Tumor Effects on MCF7 Breast Cancer in Mouse Study

Researchers have identified potential therapeutic effects of cold plasma-activated water (CPAW) in combating MCF7 breast cancer tumors, according to findings from preclinical studies conducted on mouse models. The study highlights the possible application of CPAW as a novel approach to addressing breast cancer, which remains one of the leading causes of cancer-related deaths worldwide.

The research focused on evaluating the impact of CPAW on tumor growth in laboratory settings. Cold plasma-activated water, created by exposing water to cold atmospheric plasma, is known for its reactive oxygen and nitrogen species, which are believed to play a role in targeting cancer cells. In this study, scientists observed that CPAW demonstrated significant anti-tumor activity against MCF7 breast cancer cells in mice. These findings suggest that CPAW could offer a minimally invasive alternative for future cancer treatments. Further investigation will be required to confirm its safety and efficacy before clinical applications can be considered.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 6, 2026

Author

GOAI